<div class="headers"><div>Fig 3. Efficacy endpoint. (A) Time to confirmed disease progression, all patients; (B) time to confirmed disease progression by age and baseline gadolinium-enhancing lesions. HR  hazard ratio; CI  confidence interval.</div></div><table class='gmisc_table' style='border-collapse: collapse; margin-top: 1em; margin-bottom: 1em;' >
<thead>
<tr>
<th style='border-bottom: 1px solid grey; border-top: 2px solid grey;'> </th>
<th style='border-bottom: 1px solid grey; border-top: 2px solid grey; text-align: center;'>row/col</th>
<th style='border-bottom: 1px solid grey; border-top: 2px solid grey; text-align: center;'>7(G)</th>
</tr>
</thead>
<tbody>
<tr>
<td style='border-bottom: 2px solid grey; text-align: left;'>1</td>
<td style='border-bottom: 2px solid grey; text-align: left;'>1</td>
<td style='border-bottom: 2px solid grey; text-align: left;'><p class="">Fig 3. Efficacy endpoint. (A) Time to confirmed disease progression, all patients; (B) time to confirmed disease progression by age and baseline gadolinium-enhancing lesions. HR  hazard ratio; CI  confidence interval.</p></td>
</tr>
</tbody>
</table>
